BLIMP1 against Lymphoma: The Verdict Is Reached

Research output: Contribution to journalShort surveypeer-review

3 Scopus citations


BLIMP1, a master regulator of plasma-cell differentiation, is implicated in the pathogenesis of Activated B cell (ABC)-like Diffuse Large B cell Lymphoma (DLBCL). In this issue of Cancer Cell, Mandelbaum and colleagues and Calado and colleagues unequivocally demonstrate that BLIMP1 functions as a tumor suppressor and guardian of ABC-like DLBCL lymphomagenesis.

Original languageEnglish (US)
Pages (from-to)537-539
Number of pages3
JournalCancer Cell
Issue number6
StatePublished - Dec 14 2010

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research


Dive into the research topics of 'BLIMP1 against Lymphoma: The Verdict Is Reached'. Together they form a unique fingerprint.

Cite this